Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fluor (FLR) Receivables (2016 - 2025)

Fluor (FLR) has disclosed Receivables for 17 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • Quarterly Receivables rose 12.58% to $2.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, up 12.58% year-over-year, with the annual reading at $2.2 billion for FY2025, 12.58% up from the prior year.
  • Receivables for Q4 2025 was $2.2 billion at Fluor, up from $1.6 billion in the prior quarter.
  • The five-year high for Receivables was $2.2 billion in Q4 2021, with the low at $1.1 billion in Q3 2021.
  • Average Receivables over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2025.
  • The sharpest move saw Receivables plummeted 52.43% in 2021, then surged 91.48% in 2022.
  • Over 5 years, Receivables stood at $2.2 billion in 2021, then tumbled by 50.83% to $1.1 billion in 2022, then skyrocketed by 81.0% to $2.0 billion in 2023, then dropped by 1.0% to $2.0 billion in 2024, then rose by 12.58% to $2.2 billion in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $2.2 billion, $1.6 billion, and $1.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.